Guillain–Barré syndrome and catecholamine therapy. A potential risk for developing takotsubo cardiomyopathy?
Authors:
- Silvio QuickSQSilvio Quick
- Carmen QuickCQCarmen Quick
- Ralph SchneiderRSRalph Schneider
- Krunoslav SvericKSKrunoslav Sveric
- Stefanie KatzkeSKStefanie Katzke
- Ruth H. StrasserRSRuth H. Strasser
- Karim IbrahimKIKarim Ibrahim
- 1 May 2013
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 165 (3) , e43-e44
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Intracranial hemorrhage causes a transmural myocardial infarction without the presence of coronary atherosclerosisInternational Journal of Cardiology, 2011
- Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin–norepinephrine reuptake inhibitor VenlafaxineEuropean Neuropsychopharmacology, 2010
- The nervous heart: a case report and discussion of an under-recognized clinical problemQJM: An International Journal of Medicine, 2009
- Stress (Takotsubo) cardiomyopathy—a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunningNature Clinical Practice Cardiovascular Medicine, 2008
- Association of cardiomyopathy caused by autonomic nervous system impairment with the Miller Fisher syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Reversible Left Ventricular Dysfunction Associated with Guillain-Barre Syndrome. An Expression of Catecholamine Cardiotoxicity?Japanese Circulation Journal, 1995
- In vivo measurement of neuronal uptake of norepinephrine in the human heart.Circulation, 1988